Xenon-133

Changed by Daniel J Bell, 16 Sep 2018

Updates to Article Attributes

Body was changed:

Xenon-133 is a radiopharmaceutical principally used when a performing VQ scan. Inhalation of this gas can also be used to assess cerebral blood flow.

  • photon energy: 81 KeV
  • physical half-life: 5.27 days
  • biological half-life: 30 seconds
  • normal distribution: lungs
    • <15% of inhaled gas is absorbed
  • excretion: lungs
  • target organ: lungs

Xenon-133 is a fission product from uranium-235. The gas is normally supplied in a concentration of 5% inwith 95% carbon dioxide.

Uses, dosages, and time of imaging

V/Q scan: ventilation agent
  • dose: 370-740 MBq (10-20 mCi) inhaled
  • time of imaging: immediate
  • -</ul><p>Xenon-133 is a fission product from uranium-235. The gas is normally supplied in a concentration of 5% in 95% carbon dioxide.</p><h4>Uses, dosages, and time of imaging</h4><h5>V/Q scan: ventilation agent</h5><ul>
  • -<li>dose: 370-740 MBq inhaled</li>
  • +</ul><p>Xenon-133 is a fission product from uranium-235. The gas is normally supplied in a concentration of 5% with 95% carbon dioxide.</p><h4>Uses, dosages, and time of imaging</h4><h5>V/Q scan: ventilation agent</h5><ul>
  • +<li>dose: 370-740 MBq (10-20 mCi) inhaled</li>

Systems changed:

  • Central Nervous System

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.